Recent Headlines
Within Pharmaceuticals
Makers Nutrition Launches Premium Stock Formulas
Fast-Growing Nutraceutical Company Offers Nine Popular Stock Formulas to Vitamin and Supplement Businesses - March 08, 2016 - Makers Nutrition, LLC
Stem Cell Oncology – Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Stem Cell Oncology –Pipeline Insights, 2016 to its portfolio. With this launch, DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this, DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - March 08, 2016 - DelveInsight
New Detectable Markers Make Food Safer to Produce
Halve the chance of plastic contaminated food by using Detectamet’s one piece detectable markers. Food safe marker inks have been put into a patented retractable housing so that a potential source of contamination can be removed from the processing area. Furthermore, the one piece housing is made from Detectamet’s metal and X-ray detectable plastic so plastic contamination risks are reduced. - March 07, 2016 - Detectamet
Specialty CROs: The Future of R&D Outsourcing
Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/services, focused on a particular stage of clinical... - March 07, 2016 - Roots Analysis
National Sales Manager Announced for Stat-Technologies
Stat-Technologies, the premier distributor of point of care testing products, announced today that they have promoted Angela Hansen to National Sales Manager. Angela has been with Stat since 2008 as a territory representative and marketing manager for Oxygen, the paperless data collection... - March 05, 2016 - Stat-Technologies
Spaulding Clinical Research, a Full-Service CRO to Present at the American Society for Clinical Pharmacology and Therapeutics' (ASCPT) 2016 Annual Meeting
Spaulding Clinical Research, LLC, a full-service CRO announced today that they will be in attendance at the American Society for Clinical Pharmacology and Therapeutics’ (ASCPT) 2016 Annual Meeting. The event is scheduled to take place at the Hilton Bayfront in San Diego, California a from... - March 05, 2016 - Spaulding Clinical Research, LLC
Friends Salon N Spa Offers Phyto Sintesi Lifting Serum at a Discount on Online Purchase
Experience beautiful, tighter skin by using the innovative Phyto Sintesi Lifting Serum comprising several natural active ingredients. Overcome the signs of premature aging with the power of vegetal extracts, caffeine and vitamins. The serum is offered at a discount now. - March 04, 2016 - Friends Salon N Spa
March 31, 2016 Webinar: U.S.'s Largest Commercial Episodes of Care Payor on Payor-Provider Partnership That Improved Clinical Outcomes & Reduced Total Cost of Care
Horizon Blue Cross Blue Shield New Jersey (BCBSNJ) will outline the value-based payor-provider partnership that yielded $3 million in shared savings in 2014 for 51 participating specialty practices during a March 31, 2016 webinar sponsored by the Healthcare Intelligence Network. - March 03, 2016 - Healthcare Intelligence Network
IQ4I Research & Consultancy Published a New Report on “Structural Heart Devices Global Market – Forecast To 2022”
This analyzes and studies the overall market, major drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World. - March 03, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 03, 2016 - DelveInsight
Silver Wolf Nutrition Launches Effective New Protein Powder Made from Peas
Silver Wolf Nutrition has launched a new type of protein powder made exclusively from peas. The product offers 30 grams of protein in a relatively small amount of powder, giving people a vegan, cost-effective, and hypoallergenic solution to their diet and muscle building needs. - March 02, 2016 - Silver Wolf Nutrition
FLAG Therapeutics Announces the Granting of Orphan Drug Designation to FLAG-003 in Both the US and EU for the Treatment of Glioma
FLAG Therapeutics Inc. announced today that the U.S. Food and Drug Administration’s Office of Orphan Products Development and the European Medicines Agency (EMA) have both granted Orphan Drug Designation to FLAG-003 for the treatment of glioma. Gliomas (including Glioblastoma) are the most... - March 02, 2016 - FLAG Therapeutics
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
March 29, 2016 Webinar Will Measure and Evaluate the Impact of Home Visits for Clinically Complex Patients
Community Care of North Carolina will describe the framework and impact of its technology-driven post-discharge home visit intervention for clinically complex Medicaid patients during a March 29, 2016 webinar sponsored by the Healthcare Intelligence Network. - February 29, 2016 - Healthcare Intelligence Network
Dr. Edward Paul Presents Macular Degeneration Update at Harvard
Seventy-four percent of Americans did not know that age-related macular degeneration (AMD) is the leading cause of blindness in people in the United States over the age of 60, according to a new survey. The top choice selected was, incorrectly, glaucoma. Despite the high prevalence of AMD, the... - February 28, 2016 - Paul Vision Institute
Speaking of NEC Podcast Retrospective Launches February 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 27, 2016 - The Morgan Leary Vaughan Fund, Inc.
Clinical Research Forum Congratulates Co-Founder on U.S. Food and Drug Administration Appointment
Formed in 1996, the Clinical Research Forum convenes annually to allow industry leaders to discuss issues facing the field, best practices, and promote understanding and support for clinical research and its impact on health and healthcare. Through its activities, the Forum has increasingly played a national advocacy role in supporting broader interests and needs of clinical research. For more information, visit www.clinicalresearchforum.org. - February 26, 2016 - Clinical Research Forum
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 26, 2016 - DelveInsight
The Addictions Academy Offers Free Training to Drug Torn Liberty City
The Addictions Academy and Cali Estes offers a free intervention training to an advocate in Liberty City to assist with the drug epidemic in an area where resources are limited. - February 26, 2016 - The Addictions Academy
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
Makers Nutrition Hires Stephen Finnegan as General Manager
Rapidly growing nutraceutical company turns to seasoned executive to help lead expansion. - February 25, 2016 - Makers Nutrition, LLC
Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report STAT3 inhibitors-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - February 25, 2016 - DelveInsight
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - February 25, 2016 - DelveInsight
IQ4I Research & Consultancy Published a New Report on “Vascular Closure Devices Global Market – Forecast To 2022”
IQ4I’s Report Contains 73 market data tables and 35 figures spread through 205 pages and an exhaustive TOC on “Vascular Closure Devices Global Market [Type (Active {Clips, Suture-mediated devices & Plugs [Collagen based, Polymer based, Femoral Introducer Sheath and Hemostasis Device (FISH)]} & Passive {Hemostatic Pads/Patches & Compression devices}); Intervention (Diagnostic & Therapeutic); Access (Femoral & Radial); Regional (North America, Europe, Asia Pacific and Rest of the World)] - February 24, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Wego Health to Demonstrate the Importance of Patient Influencers During ePharma Summit 2016
Company will ask for a single question to show how the pharmaceutical industry can benefit from engaging patient community leaders. - February 24, 2016 - Wego Health
MR Solutions Brings New 3D, 1000X Magnification Imaging Modality to Preclinical Research
MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs. - February 24, 2016 - MR Solutions
ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility
ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and... - February 23, 2016 - ALPCO
AdvantaPure(R) Introduces AdvantaFlex® Sterile Molded Tubing Ends to Add Versatility to Tubing
Single-Use, molded, mini Tri-Clamp tubing ends are designed to improve production and reduce operational costs involved with biopharma processes. Made from AdvantaFlex biopharmaceutical grade TPE tubing and an overmolding process, the ends are well suited for aseptic fluid transfer applications. They reduce the potential for leaks and help simplify cleaning and validation procedures. AdvantaFlex Molded Tubing Ends are compatible with sterile tubing welders. - February 21, 2016 - AdvantaPure
Saint-Gobain Seals Opens Large Diameter, OmniSeal® Seal Production Facility in Kontich, Belgium
Saint-Gobain Seals has opened a new large diameter seal production facility at its Kontich, Belgium site in order to further improve quality and reduce lead-times significantly for large diameter, polymer OmniSeal® seals. With this new production facility, Saint-Gobain Seals aims to strengthen... - February 20, 2016 - Saint-Gobain Performance Plastics, Seals Group
PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has a strong presence in the Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 has received great response and feedback from clients. - February 19, 2016 - DelveInsight
BFTP Announces Second Investment in Series A Funding for CRO Analytics
Additional investment based on positive results of the Pilot to Production program for company’s Clinical Trial Performance System, PerformerTM. - February 19, 2016 - CRO Analytics
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 19, 2016 - DelveInsight
Fannin Innovation Studio Names Melissa Singh Principal
Life science commercialization company Fannin Innovation Studio (www.FanninInnovation.com) today promoted its first entrepreneur fellow, biomedical scientist Melissa Singh, Ph.D., to principal. With this move, entrepreneur fellow Erol Bakkalbasi, M.Sc. has been named senior entrepreneur... - February 17, 2016 - Fannin Partners, LLC
ImmunoReagents Introduces LigaTrap™ Purification Resins and Kits
ImmunoReagents is proud to announce LigaTrap™ purification resins and kits. LigaTrap™ technology utilizes novel, patented ligands, designed for antibody purification. Each kit includes 10 spin columns filled with LigaTrap™ resin and buffers needed to capture species-specific... - February 17, 2016 - ImmunoReagents Inc.
ALPCO Releases New Basophil Activation Test Validated for the Evaluation of Kinase Inhibitors in Early Drug Development
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016 - ALPCO
Peptide Therapeutics: The Growing Hope for Metabolic Disorders
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook of the evolving pipeline of peptide therapeutics that are being... - February 16, 2016 - Roots Analysis
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
NuvOx Pharma receives FDA Orphan Drug Designation for Oxygen Therapeutic for Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of... - February 14, 2016 - NuvOx Therapeutics
Don Barbo Returns to VMG Health’s Business Valuation Practice
VMG Health welcomes back Don Barbo as a managing director in healthcare business valuation services. - February 13, 2016 - VMG Health
NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for Vaso-Occlusive Crisis in Sickle Cell Disease
The FDA has notified NuvOx Pharma that it may proceed with a clinical trial for its Investigational New Drug (IND), NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of sickle cell disease and it typically... - February 13, 2016 - NuvOx Therapeutics
cliexa™ Launched Its first Rheumatoid Arthritis Disease Activity Tracking Mobile Application, cliexa-RA
Collaborative Network 4 Clinical Excellence, LLC (CN4CE) has just launched their first mobile chronic disease tracking application, cliexa-RA. cliexa-RA is available for iOS devices in the App Store. It tracks medications, symptoms and disease activity for Rheumatoid Arthritis. The Clinical... - February 13, 2016 - cliexa
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
Fertility Preservation Network Welcomes Albuquerque, New Mexico Facility
Program greatly extends access to fertility preservation services - February 12, 2016 - ReproTech, LLC
Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens
Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.
Advanced Electrophoresis Solutions Signs an Exclusive Distributor Partner for Europe
AES (Advanced Electrophoresis Solutions Ltd.), a pioneer in designing and manufacturing the most reliable, high performance, and high throughput CEInfinite whole column imaging detection capillary isoelectric focusing (iCIEF) systems, proprietary cartridges, ampholytes, and pI standards for the... - February 11, 2016 - Advanced Electrophoresis Solutions Ltd.
PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology-based Indications & Mechanism of Action (MOA). - February 10, 2016 - DelveInsight
Assessment Shows Nation’s Guard is Down Against Zika Virus and Mosquito-Borne Diseases
The Council of State and Territorial Epidemiologists (CSTE) supports President Barack Obama’s request of $1.8 billion to combat Zika virus. Declared a “global health emergency” by the World Health Organization, Zika virus increasingly threatens to spread local epidemics in the... - February 08, 2016 - Council of State and Territorial Epidemiologists
NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. - February 08, 2016 - NanoCellect
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Vivonics Sells Artificial Lung Technology
Vivonics, Inc. announced today the sale of intellectual property and other assets related to its Artificial Lung technology to Lung Biotechnology PBC, a wholly-owned subsidiary of United Therapeutics Corporation. Vivonics’ development of the Artificial Lung technology was supported by the... - February 04, 2016 - Vivonics, Inc.